The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation

Nature Immunology

Volumn 11, Issue 6, 2010, Pages 527-534

  Chang, Hua Chen ^a   Sehra, Sarita ^a   Goswami, Ritobrata ^a   Yao, Weiguo ^a   Yu, Qing ^a   Stritesky, Gretta L ^a   Jabeen, Rukhsana ^a   McKinley, Carl ^a   Ahyi, Ayele Nati ^a   Han, Ling ^a   Nguyen, Evelyn T ^a   Robertson, Michael J ^a   Perumal, Narayanan B ^b   Tepper, Robert S ^a   Nutt, Stephen L ^c   Kaplan, Mark H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 9; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PU 1;

ALLERGY; ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GENE DELETION; HELPER CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; T LYMPHOCYTE; TH2 CELL; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; FEMALE; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INTERLEUKIN-9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANS-ACTIVATORS;

EID: 77952584843     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1867     Document Type: Article

References (44)

1. Dong, C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8, 337-348 (2008).
2. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517 (2009).
3. Weaver, C.T., Harrington, L.E., Mangan, P.R., Gavrieli, M. & Murphy, K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677-688 (2006).
4. Ansel, K.M., Djuretic, I., Tanasa, B. & Rao, A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24, 607-656 (2006).
5. Lee, G.R., Kim, S.T., Spilianakis, C.G., Fields, P.E. & Flavell, R.A. T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24, 369-379 (2006).
6. Murphy, K.M. & Reiner, S.L. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2, 933-944 (2002).
7. Chang, H.C. et al. PU.1 regulates TCR expression by modulating GATA-3 activity. J. Immunol. 183, 4887-4894 (2009).
8. Chang, H.C. et al. PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 22, 693-703 (2005).
9. Ahyi, A.N., Chang, H.C., Dent, A.L., Nutt, S.L. & Kaplan, M.H. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J. Immunol. 183, 1598-1606 (2009).
10. Hauber, H.P., Bergeron, C. & Hamid, Q. IL-9 in allergic infammation. Int. Arch. Allergy Immunol. 134, 79-87 (2004).
11. Forbes, E.E. et al. IL-9-and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J. Exp. Med. 205, 897-913 (2008).
12. Temann, U.A., Geba, G.P., Rankin, J.A. & Flavell, R.A. Expression of interleukin 9 in the lungs of transgenic mice causes airway infammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188, 1307-1320 (1998).
13. Temann, U.A., Ray, P. & Flavell, R.A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109, 29-39 (2002).
14. Steenwinckel, V. et al. IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J. Immunol. 182, 4737-4743 (2009).
15. Steenwinckel, V. et al. IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J. Immunol. 178, 3244-3251 (2007).
16. Temann, U.A., Laouar, Y., Eynon, E.E., Homer, R. & Flavell, R.A. IL9 leads to airway infammation by inducing IL13 expression in airway epithelial cells. Int. Immunol. 19, 1-10 (2007).
17. Townsend, J.M. et al. IL-9-defcient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13, 573-583 (2000).
18. Cheng, G. et al. Anti-interleukin-9 antibody treatment inhibits airway infammation and hyperreactivity in mouse asthma model. Am. J. Respir. Crit. Care Med. 166, 409-416 (2002).
19. McMillan, S.J., Bishop, B., Townsend, M.J., McKenzie, A.N. & Lloyd, C.M. The absence of interleukin 9 does not affect the development of allergen-induced pulmonary infammation nor airway hyperreactivity. J. Exp. Med. 195, 51-57 (2002).
20. Erpenbeck, V.J. et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fuid lymphocytes. J. Allergy Clin. Immunol. 111, 1319-1327 (2003).
21. Shimbara, A. et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J. Allergy Clin. Immunol. 105, 108-115 (2000).
22. White, B., Leon, F., White, W. & Robbie, G. Two frst-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers. Clin. Ther. 31, 728-740 (2009).
23. Faulkner, H., Renauld, J.C., Van Snick, J. & Grencis, R.K. Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect. Immun. 66, 3832-3840 (1998).
24. Veldhoen, M. et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346 (2008).
25. + natural regulatory T cells. Proc. Natl. Acad. Sci. USA 106, 12885-12890 (2009).
26. Nowak, E.C. et al. IL-9 as a mediator of Th17-driven infammatory disease. J. Exp. Med. 206, 1653-1660 (2009).
27. + T cells depends on IL-2, is synergistically enhanced by a combination of TGF-β and IL-4, and is inhibited by IFN-γ. J. Immunol. 153, 3989-3996 (1994).
28. Lu, L.F. et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997-1002 (2006).
29. - effector T cells. Nat. Immunol. 9, 1347-1355 (2008).
30. + T cells. Immunity 30, 155-167 (2009).
31. Tepper, R.S. et al. Expired nitric oxide and airway reactivity in infants at risk for asthma. J. Allergy Clin. Immunol. 122, 760-765 (2008).
32. + T cell lineage differentiation. Immunity 30, 646-655 (2009).
33. Djuretic, I.M. et al. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8, 145-153 (2007).
34. H1 gene induction. Nat. Immunol. 3, 652-658 (2002).
35. Thieu, V.T. et al. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 29, 679-690 (2008).
36. H-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8, 958-966 (2007).
37. Schnyder-Candrian, S. et al. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203, 2715-2725 (2006).
38. Gonzalo, J.A. et al. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung infammation. J. Immunol. 163, 403-411 (1999).
39. Kawasaki, S. et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway infammation and hyperresponsiveness in mice. J. Immunol. 166, 2055-2062 (2001).
40. Mikhak, Z. et al. Contribution of CCR4 and CCR8 to antigen-specifc T(H)2 cell traf-fcking in allergic pulmonary infammation. J. Allergy Clin. Immunol. 123, 67-73 (2009).
41. Wills-Karp, M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202, 175-190 (2004). (Pubitemid 39576912)
42. Dakic, A. et al. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 201, 1487-1502 (2005).
43. Stritesky, G.L., Yeh, N. & Kaplan, M.H. IL-23 mediates stability but not commitment to the Th17 lineage. J. Immunol. 181, 5948-5955 (2008).
44. van Rijt, L.S. et al. A rapid fow cytometric method for determining the cellular composition of bronchoalveolar lavage fuid cells in mouse models of asthma. J. Immunol. Methods 288, 111-121 (2004).